Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1995-01-23
1997-05-06
Rollins, John W.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241581, 4241301, 514885, A61K 39395
Patent
active
056268459
ABSTRACT:
Materials immunoreactive with parathyroid hormone-related protein (PTH-rp) are used in the invention method to prevent and treat metastasis and cancer cell growth in bone as well as osteolysis and symptomatic sequelae thereof. Humanized antibodies are included in the invention for application of the invention method to human subjects.
REFERENCES:
patent: 5114843 (1992-05-01), Rosenblatt et al.
patent: 5116952 (1992-05-01), Martin et al.
patent: 5217896 (1993-06-01), Kramer et al.
patent: 5312810 (1994-05-01), Wood et al.
Tashjian, A.H. et al., "Immunochemical identification of parathyroid hormone in non-parathyroid neoplasms associated with hypercalcemia," J. Exp. Med., 119:467-484 (1994).
Suva et al., "A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression," Science, 237:893-896, (Aug. 1987).
Southby et al., "Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer," Cancer Res., 50:7710-7716 (Oct. 1990).
Burton et al., "Parathyroid hormone related peptide can function as an autocrine growth factor in human renal cell carcinoma," Biochem. Biophys. Res. Comm., 167(3):1134-1138 (Mar. 1990).
Powell et al., "Localization of parathyroid hormone-related protein in breast cancer metastases: Increased incidence in bone compared with other sites," Cancer Res., 51(11):3059-3061 (Jun. 1991).
Yoneda et al., "Occurrence of hypercalcemia and leukocytosis with cachexia in a human squamous cell carcinoma of the maxilla in athymic nude mice: a novel experimental model of three concomitant paraneoplastic syndromes," J. Clin. Oncol., 9(3):468-477 (Mar. 1991).
Abou-Samra et al., "Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: A single receptor stimulates intracellular accumulation of both cAMP and iinositol trisphosphates and increases intracellular free calcium," Proc. Natl. Acad. Sci. USA, 89:2732-2736 (Apr. 1992).
Nakai et al., "A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice," Cancer Res., 52:5395-5399 (Oct. 1992).
Sato et al., "Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude bearing transplanted human PTHrP-producing tumors," J. Bone Min. Res., 8(7):849-860 (Jul. 1993).
Kohno et al., "The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases," Surgery Today, Japan J. Surg. 4:215-220 (1993).
Sasaki et al., "Growth of metastatic cancer in bone is impaired by inhibitors of bone resorption in vivo," J. Bone Min. Res., 8(1):S139 (Aug. 1993).
Li et al., "Growth factor-like properties of parathyroid hormone-related peptide in transfected rodent cell lines," Cancer Res., 53(13):2980-2986 (Jul. 1993).
Guise et al., "Parathyroid hormone-related protein (PTHrP) expression by breast cancer cells enhance osteolytic bone metastases in vivo" Breast Cancer Res. Treat., 32(supppl): 91 (1994).
Mundy Gregory R.
Yoneda Toshiyuki
Bozicevic Karl
Rollins John W.
Xenotech Incorporated
LandOfFree
Method to ameliorate osteolysis and metastasis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to ameliorate osteolysis and metastasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to ameliorate osteolysis and metastasis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2130481